Lucentis Costing Medicare $1 Billion

An analysis of medicare data shows that Lucentis, a treatment for wet macular degeneration is costing Medicare in the United States approximately $1 Billion per year. Researchers and eye care … [Read more...]

Lucentis Treatment coming to Cape Breton, Nova Scotia

People diagnosed with wet macular degeneration in the Cape Breton, Nova Scotia area will now have access to lucentis as a treatment option.  Premier Darrell Dexter made the announcement indicating … [Read more...]

Nova Scotia Contemplates Lucentis Treatment

Nova Scotia is contemplating providing coverage for Lucentis, the leading macular degeneration treatment. According to Maureen MacDonald, Nova Scotia's health minister, the province may pay for … [Read more...]

New Brunswick Covers Lucentis Treatments for Wet Macular Degeneration

Lucentis, the leading treatment for the eye disease wet macular degeneration is now covered through the New Brunswick Prescription Drug Plan (NBPDP).  The November 16 announcement ensures that people … [Read more...]

British Columbia Approves Lucentis Funding for Macular Degeneration

Source - The Canadian Press VICTORIA, B.C. — The B.C. government will start funding two new drugs to treat people suffering from a disease that could cause blindness for seniors. Health Minister … [Read more...]